Atlas Trials

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

Clinical trial NCT06252870 · RECRUITING

Trial details

NCT number
NCT06252870
Sponsor
Nantes University Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseHematologic Malignancy
Start date
2024-07-18
Primary completion
2027-10-18
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.